Concepedia

Author

Hamdi Sati

Oslo University Hospital

Also Known As

H. I. A. Sati, H. I. Sati, Hamdi I. A. Sati, Hamdi Sati, Samir Turk, Taishi Sasaoka

19

Publications

1K

Citations

10

H-Index

26

Concepts

All Affiliations

Oslo University HospitalNational and Kapodistrian University of AthensUniversity of AberdeenUniversity of OsloUniversity of Ulster
HS

About

Hamdi Sati is an author at Oslo University Hospital specializing in medicine, cell transplantation, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

668

2

Health Sciences

1

1

375

3

Cellular Therapies

1

1

231

4

Diabetes

1

1

62

5

Epidemiology

1

1

62

Hamdi Sati

×

9

Publications

956

Citations

9

H-Index

YearCitations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç,

The Lancet Oncology

2019

375

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold,

The Lancet

2018

231

Expression of interleukin‐1β and tumour necrosis factor‐α in plasma cells from patients with multiple myeloma

Hamdi Sati, M. Greaves, Jane F. Apperley,

British Journal of Haematology

1999

92

Pamidronate causes apoptosis of plasma cells <i>in vivo</i> in patients with multiple myeloma

Sharon Gordon, Miep Helfrich, Hamdi Sati,

British Journal of Haematology

2002

62

Incidence and associations of acute renal failure complicating high‐dose intravenous immunoglobulin therapy

Hamdi Sati, R. Ahya, Heather Watson

British Journal of Haematology

2001

62

Interleukin‐6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance

Hamdi Sati, Jane F. Apperley, M. Greaves,

British Journal of Haematology

1998

46

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Giulio Francesco Romiti, Bernadette Corica, Marco Proietti,

EClinicalMedicine

2023

38

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman,

Journal of Clinical Oncology

2024

31

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial

Meletios Α. Dimopoulos, Fredrik Schjesvold, Vadim Doronin,

Blood Cancer Journal

2022

19

Page 1